Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001070081-18-000046
Filing Date
2018-04-30
Accepted
2018-04-30 17:26:01
Documents
5
Period of Report
2018-06-13
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A ptct2018proxy.htm DEF 14A 1366746
2 ceoneo2017graphic.jpg GRAPHIC 63568
3 g683229a01.jpg GRAPHIC 6822
4 ptca01.jpg GRAPHIC 8644
5 signature.jpg GRAPHIC 11050
  Complete submission text file 0001070081-18-000046.txt   1485739
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35969 | Film No.: 18791542
SIC: 2834 Pharmaceutical Preparations